Pharmarise Holdings Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3802320006
  • TKS: 2796
JPY
504.00
-3 (-0.59%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
May'26
May'25
May'24
May'23
May'22
May'21
May'20
Net Sales
69,512.00
63,508.00
54,466.00
52,030.00
51,608.00
52,324.00
51,030.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
69,512.00
63,508.00
54,466.00
52,030.00
51,608.00
52,324.00
51,030.00
Raw Material Cost
60,876.00
55,305.00
46,574.00
44,531.00
44,191.00
44,994.00
44,298.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
285.00
178.00
66.00
55.00
65.00
75.00
74.00
Selling and Distribution Expenses
4,440.00
4,851.00
4,359.00
3,715.00
3,514.00
3,644.00
3,500.00
Other Expenses
-27.50
-16.90
-5.40
-4.20
-5.40
-5.30
-6.50
Total Expenditure (Excl Depreciation)
65,326.00
60,165.00
50,945.00
48,259.00
47,716.00
48,660.00
47,807.00
Operating Profit (PBDIT) excl Other Income
4186
3343
3521
3771
3892
3664
3223
Other Income
11.00
21.00
-4.00
1.00
-21.00
85.00
120.00
Operating Profit (PBDIT)
2,596.00
1,809.00
2,082.00
2,664.00
2,808.00
2,676.00
2,345.00
Interest
285.00
178.00
66.00
55.00
65.00
75.00
74.00
Exceptional Items
-8.00
-129.00
-703.00
-334.00
-112.00
-56.00
-228.00
Gross Profit (PBDT)
8,636.00
8,203.00
7,892.00
7,499.00
7,417.00
7,330.00
6,732.00
Depreciation
1,605.00
1,493.00
1,170.00
1,224.00
1,308.00
1,344.00
1,228.00
Profit Before Tax
698.00
8.00
143.00
1,049.00
1,322.00
1,202.00
819.00
Tax
591.00
390.00
485.00
702.00
864.00
782.00
238.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
113.00
-368.00
-351.00
333.00
448.00
425.00
577.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
113.00
-368.00
-351.00
333.00
448.00
425.00
577.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-6.00
-13.00
9.00
14.00
10.00
-6.00
3.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
107.00
-381.00
-342.00
347.00
458.00
419.00
580.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,842.00
6,869.00
7,362.00
6,882.00
6,608.00
6,221.00
5,909.00
Earnings per share (EPS)
9.56
-32.42
-33.35
26.86
36.22
34.59
46.32
Diluted Earnings per share
9.56
-32.42
-33.35
26.86
36.22
34.59
46.32
Operating Profit Margin (Excl OI)
1.41%
0.46%
1.68%
2.77%
2.95%
2.38%
1.95%
Gross Profit Margin
3.31%
2.36%
2.41%
4.37%
5.1%
4.87%
4.01%
PAT Margin
0.16%
-0.58%
-0.64%
0.64%
0.87%
0.81%
1.13%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended May 2026 is 9.45% vs 16.60% in May 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended May 2026 is 128.08% vs -11.40% in May 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended May 2026 is 44.57% vs -14.29% in May 2025

stock-summary

Interest

YoY Growth in year ended May 2026 is 60.11% vs 169.70% in May 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended May 2026 has improved from May 2025

Compare Annual Results Of Pharmarise Holdings Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
69,512.00
68.55
69,443.45
101,303.36%
Other Operating Income
0.00
0.00
0.00
Total Operating income
69,512.00
68.55
69,443.45
101,303.36%
Raw Material Cost
60,876.00
4.35
60,871.65
1,399,348.28%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
33.30
-33.30
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
285.00
0.00
285.00
Selling and Distribution Expenses
4,440.00
195.96
4,244.04
2,165.77%
Other Expenses
-27.50
16.84
-44.34
-263.30%
Total Expenditure (Excl Depreciation)
65,326.00
401.96
64,924.04
16,151.87%
Operating Profit (PBDIT) excl Other Income
4,186.00
-333.41
4,519.41
1,355.51%
Other Income
11.00
56.61
-45.61
-80.57%
Operating Profit (PBDIT)
2,596.00
-300.27
2,896.27
964.56%
Interest
285.00
0.00
285.00
Exceptional Items
-8.00
0.00
-8.00
Gross Profit (PBDT)
8,636.00
64.21
8,571.79
13,349.62%
Depreciation
1,605.00
0.00
1,605.00
Profit Before Tax
698.00
-300.27
998.27
332.46%
Tax
591.00
1.00
590.00
59,000.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
113.00
-301.28
414.28
137.51%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
113.00
-301.28
414.28
137.51%
Share in Profit of Associates
0
0
0.00
Minority Interest
-6.00
0.00
-6.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
107.00
-301.28
408.28
135.52%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
6,842.00
3,322.68
3,519.32
105.92%
Earnings per share (EPS)
9.56
-23.39
32.95
140.87%
Diluted Earnings per share
9.56
-23.39
32.95
140.87%
Operating Profit Margin (Excl OI)
1.41%
-520.59%
0.00
522.00%
Gross Profit Margin
3.31%
-438.01%
0.00
441.32%
PAT Margin
0.16%
-439.47%
0.00
439.63%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 6,951.20 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 9.45% vs 16.60% in May 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 10.70 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 128.08% vs -11.40% in May 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 258.50 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 44.57% vs -14.29% in May 2025

Annual - Interest
Interest 28.50 Million
in May 2026

Figures in Million
stock-summary

YoY Growth in year ended May 2026 is 60.11% vs 169.70% in May 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.41%
in May 2026

Figures in %
stock-summary

YoY Growth in year ended May 2026 has improved from May 2025

Footer loading